Please login to the form below

Not currently logged in
Email:
Password:

Bedford Laboratories

This page shows the latest Bedford Laboratories news and features for those working in and with pharma, biotech and healthcare.

Hikma pays $2.6bn for Boehringer’s US generics unit

Hikma pays $2.6bn for Boehringer’s US generics unit

The latest deal in the sector comes just over a year after Boehringer sold its troubled sterile injectables subsidiary Bedford Laboratories to Hikma in a deal valued at $300m. ... Hikma also gained ownership of Bedford's portfolio of 84 generic

Latest news

  • Boehringer planning job cuts in Germany Boehringer planning job cuts in Germany

    Bedford Laboratories to Hikma.

  • Boehringer sells injectables business to Hikma for $300m Boehringer sells injectables business to Hikma for $300m

    Bedford Laboratories is part of troubled Ben Venue division. Boehringer Ingelheim has sold troubled sterile injectables subsidiary Bedford Laboratories to Hikma Pharmaceuticals in a deal valued at $300m. ... US-based Bedford, part of Boehringer's Ben

  • Otsuka files new TB candidate in Japan as shortages worsen Otsuka files new TB candidate in Japan as shortages worsen

    Rifampin shortage. On the downside, Pfizer and Bedford Laboratories have said manufacturing problems are affecting supplies of rifampin, which remains a cornerstone of TB therapy despite being launched several decades ago. ... In Bedford's case, the

  • FDA says approval of generic Doxil will ease cancer drug shortage FDA says approval of generic Doxil will ease cancer drug shortage

    These issues have also affected other cancer drugs, including methotrexate, versions of which are made by Mylan, Sandoz, Hospira and Bedford Laboratories. ... Janssen said it was working with the FDA to gain approval for this new manufacturing process

  • MS treatment hopes

    USA. Levetiracetam. (Dr. Reddy's Laboratories). Epilepsy. USA . Lithium. (Glenmark Generics). Bipolar Disorders. ... Silodosin. Urief (Daiichi-Sankyo and Kissei Pharmaceutical). Dysuria. Japan. Sumatriptan. (Bedford Laboratories).

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Huntingdon Life Sciences appoints Joseph Bedford Huntingdon Life Sciences appoints Joseph Bedford

    Huntingdon Life Sciences and Harlan Laboratories have appointed Joseph Bedford as corporate vice president for global strategic marketing. ... development. Dr Adrian Hardy, chief operating officer at Huntingdon Life Sciences and Harlan Laboratories, said:

  • Par hires Antonio Pera as commercial head Par hires Antonio Pera as commercial head

    His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics